ArticleEMBO molecular medicine2023

Discovery of oncogenic ROS1 missense mutations with sensitivity to tyrosine kinase inhibitors.

Sudarshan R Iyer et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.